-+ 0.00%
-+ 0.00%
-+ 0.00%

*Ventyx Biosciences Topline Data From Multiple Phase 2 Studies Expected Throughout 2025 >VTYX

Dow Jones·05/08/2025 20:04:00

Please log in to view news